J-1090

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameJ-1090
Drug Alias NameJ-1090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitorsP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinaseTransforming growth factor beta receptor 1
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYanbian University Of Jilin Province
China Registration ClassN/A

Develop Information

Active CompaniesYanbian University Of Jilin Province
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A